Novel late-onset Alzheimer disease loci variants associate with brain gene expression
Mariet Allen,Fanggeng Zou,High Seng Chai,Curtis S Younkin,Julia Crook,V Shane Pankratz,Minerva M Carrasquillo,Christopher N Rowley,Asha A Nair,Sumit Middha,Sooraj Maharjan,Thuy Nguyen,Li Ma,Kimberly G Malphrus,Ryan Palusak,Sarah Lincoln,Gina Bisceglio,Constantin Georgescu,Debra Schultz,Fariborz Rakhshan,Christopher P Kolbert,Jin Jen,Jonathan L Haines,Richard Mayeux,Margaret A Pericak-Vance,Lindsay A Farrer,Gerard D Schellenberg,Ronald C Petersen,Neill R Graff-Radford,Dennis W Dickson,Steven G Younkin,Nilüfer Ertekin-Taner,Alzheimer's Disease Genetics Consortium (ADGC),Liana G Apostolova,Steven E Arnold,Clinton T Baldwin,Robert Barber,Michael M Barmada,Thomas Beach,Gary W Beecham,Duane Beekly,David A Bennett,Eileen H Bigio,Thomas D Bird,Deborah Blacker,Bradley F Boeve,James D Bowen,Adam Boxer,James R Burke,Jacqueline Buros,Joseph D Buxbaum,Nigel J Cairns,Laura B Cantwell,Chuanhai Cao,Chris S Carlson,Regina M Carney,Steven L Carroll,Helena C Chui,David G Clark,Jason Corneveaux,Carl W Cotman,Paul K Crane,Carlos Cruchaga,Jeffrey L Cummings,Philip L De Jager,Charles DeCarli,Steven T DeKosky,F Yesim Demirci,Ramon Diaz-Arrastia,Malcolm Dick,Beth A Dombroski,Ranjan Duara,William D Ellis,Denis Evans,Kelley M Faber,Kenneth B Fallon,Martin R Farlow,Steven Ferris,Tatiana M Foroud,Matthew Frosch,Douglas R Galasko,Paul J Gallins,Mary Ganguli,Marla Gearing,Daniel H Geschwind,Bernardino Ghetti,John R Gilbert,Sid Gilman,Bruno Giordani,Jonathan D Glass,Alison M Goate,Robert C Green,John H Growdon,Hakon Hakonarson,Ronald L Hamilton,John Hardy,Lindy E Harrell,Elizabeth Head,Lawrence S Honig,Matthew J Huentelman,Christine M Hulette,Bradley T Hyman,Gail P Jarvik,Gregory A Jicha,Lee-Way Jin,Gyungah Jun,M Ilyas Kamboh,Jason Karlawish,Anna Karydas,John S K Kauwe,Jeffrey A Kaye,Nancy Kennedy,Ronald Kim,Edward H Koo,Neil W Kowall,Patricia Kramer,Walter A Kukull,James J Lah,Eric B Larson,Allan I Levey,Andrew P Lieberman,Oscar L Lopez,Kathryn L Lunetta,Wendy J Mack,Daniel C Marson,Eden R Martin,Frank Martiniuk,Deborah C Mash,Eliezer Masliah,Wayne C McCormick,Susan M McCurry,Andrew N McDavid,Ann C McKee,Marsel Mesulam,Bruce L Miller,Carol A Miller,Joshua W Miller,Thomas J Montine,John C Morris,Amanda J Myers,Adam C Naj,Petra Nowotny,Joseph E Parisi,Daniel P Perl,Elaine Peskind,Wayne W Poon,Huntington Potter,Joseph F Quinn,Ashok Raj,Ruchita A Rajbhandary,Murray Raskind,Eric M Reiman,Barry Reisberg,Christiane Reitz,John M Ringman,Erik D Roberson,Ekaterina Rogaeva,Roger N Rosenberg,Mary Sano,Andrew J Saykin,Julie A Schneider,Lon S Schneider,William Seeley,Michael L Shelanski,Michael A Slifer,Charles D Smith,Joshua A Sonnen,Salvatore Spina,Peter St George-Hyslop,Robert A Stern,Rudolph E Tanzi,John Q Trojanowski,Juan C Troncoso,Debby W Tsuang,Vivianna M Van Deerlin,Badri Narayan Vardarajan,Harry V Vinters,Jean Paul Vonsattel,Li-San Wang,Sandra Weintraub,Kathleen A Welsh-Bohmer,Jennifer Williamson,Randall L Woltjer
DOI: https://doi.org/10.1212/WNL.0b013e3182605801
IF: 9.9
2012-07-17
Neurology
Abstract:Objective: Recent genome-wide association studies (GWAS) of late-onset Alzheimer disease (LOAD) identified 9 novel risk loci. Discovery of functional variants within genes at these loci is required to confirm their role in Alzheimer disease (AD). Single nucleotide polymorphisms that influence gene expression (eSNPs) constitute an important class of functional variants. We therefore investigated the influence of the novel LOAD risk loci on human brain gene expression. Methods: We measured gene expression levels in the cerebellum and temporal cortex of autopsied AD subjects and those with other brain pathologies (∼400 total subjects). To determine whether any of the novel LOAD risk variants are eSNPs, we tested their cis-association with expression of 6 nearby LOAD candidate genes detectable in human brain (ABCA7, BIN1, CLU, MS4A4A, MS4A6A, PICALM) and an additional 13 genes ±100 kb of these SNPs. To identify additional eSNPs that influence brain gene expression levels of the novel candidate LOAD genes, we identified SNPs ±100 kb of their location and tested for cis-associations. Results: CLU rs11136000 (p = 7.81 × 10(-4)) and MS4A4A rs2304933/rs2304935 (p = 1.48 × 10(-4)-1.86 × 10(-4)) significantly influence temporal cortex expression levels of these genes. The LOAD-protective CLU and risky MS4A4A locus alleles associate with higher brain levels of these genes. There are other cis-variants that significantly influence brain expression of CLU and ABCA7 (p = 4.01 × 10(-5)-9.09 × 10(-9)), some of which also associate with AD risk (p = 2.64 × 10(-2)-6.25 × 10(-5)). Conclusions: CLU and MS4A4A eSNPs may at least partly explain the LOAD risk association at these loci. CLU and ABCA7 may harbor additional strong eSNPs. These results have implications in the search for functional variants at the novel LOAD risk loci.